APA (7th ed.) Citation

El-Dessouki, A. M., Alzokaky, A. A., Raslan, N. A., Ibrahim, S., Selim, H. M. R. M., & Al-Karmalawy, A. A. (2025). Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(5), 5129-5145. https://doi.org/10.1007/s00210-024-03567-w

Chicago Style (17th ed.) Citation

El-Dessouki, Ahmed M., Amany A. Alzokaky, Nahed A. Raslan, Samar Ibrahim, Heba Mohammed Refat M. Selim, and Ahmed A. Al-Karmalawy. "Dabigatran Attenuates Methotrexate-induced Hepatotoxicity by Regulating Coagulation, Endothelial Dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 Signaling Pathways." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 5 (2025): 5129-5145. https://doi.org/10.1007/s00210-024-03567-w.

MLA (9th ed.) Citation

El-Dessouki, Ahmed M., et al. "Dabigatran Attenuates Methotrexate-induced Hepatotoxicity by Regulating Coagulation, Endothelial Dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 Signaling Pathways." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 5, 2025, pp. 5129-5145, https://doi.org/10.1007/s00210-024-03567-w.